Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FSHD region gene 1 family member F, pseudogene (FRG1FP) is an annotated pseudogene in the human genome, member of the FRG1 gene family, which is located in proximity to the locus associated with facioscapulohumeral muscular dystrophy (FSHD)[2][3]. Unlike the functional FRG1 gene, which is implicated in muscle biology and disease when overexpressed[4], FRG1FP does not encode a functional protein and currently lacks experimental evidence for any direct biological or clinical role. The existence of multiple FRG1 family pseudogenes reflects evolutionary duplication events in the FSHD genomic region. FRG1FP should not be considered a therapeutic target or biomarker[2][3][4]. If you need information about a functional FSHD region gene 1 family member (such as the FRG1 protein, which is involved in muscle physiology and FSHD), you may wish to clarify and request details for "FSHD region gene 1 (FRG1)" rather than the pseudogene variant[4][6].
None (No known mechanism of action for drugs, as there are no drugs interacting with FRG1FP[3].)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FSHD region gene 1 family member F, pseudogene (FRG1FP).